3rd Quarter - Report
THE MCMANUS GROUP for EMD SERONO, INC.
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare and Medicaid pharmaceutical coverage and reimbursement issues, particularly regarding neurodegenerative products. Part D reimbursement reform in H.R. 3, the Lower Drug Costs Now Act, and S. 2543, the Prescription Pricing Reduction Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTINA HOCHUL New | — |
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Health Issues HCR
General pharmaceutical coverage and reimbursement issues, health exchange policy; issues and activities affecting oncology, neurodegenerative and fertility products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.